Skip to main content
Premium Trial:

Request an Annual Quote

Oncomethylome Sciences Gets ISO Certification

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oncomethylome Sciences today said that its Belgium-based clinical diagnostics services lab has received ISO 9001:2008 certification.

The certification, which was provided by Lloyds Register Quality Assurance, confirms that the lab's quality management system "consistently meets customer and regulatory requirements for research, design, assay development, and clinical molecular diagnostic service testing," said Oncomethylome in a statement.

The Liege, Belgium-based firm makes tests based on gene methylation technology that are intended to help physicians detect the early stages of cancer development, predict response to therapy, and predict the likelihood of cancer recurrence.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.